A clinician said that recently. I have been thinking about it ever since.
Someone passed along a remark a clinician had made. The question was whether patients belong in the room where research gets designed. The clinician’s answer was clean and confident: they did not need to hear from the patient. The science speaks for itself.
I have been turning that sentence over for weeks. There is a version of it that is true, and a version of it that is wrong. They live one inch apart.
Here is the true part. Science can tell you whether a drug binds to its target. Whether a number moved, and whether it moved by more than chance. Whether an effect is real or an accident of the data. In that narrow sense, the science does speak. It is the best method we have for sorting what is true from what we wish were true.
Here is what the science cannot tell you, no matter how well the study is run: whether the thing it measured matters.
A trial can be flawless in every technical detail and still answer a question no patient ever asked.
That is the inch. A scientist can lower a pain score by a statistically significant margin, publish the result, and be completely correct. And still not know whether anyone in that study can now sleep through the night, hold a grandchild, or go back to work. The number moved. Did the life? The science does not know. Only the patient knows, and only if someone asks.
This is why I believe patients have to be part of researching and developing medicines. Not as a courtesy when there is room at the table. As a correction. Without the patient in the loop, how does a scientist know whether the thing they have given years to actually matters — whether it improves one real day for one real person? They are aiming in the dark and calling it precision.
I have sat at a lot of tables
Enough to know that a chair is the easiest thing in the world to give away.
A while back I was reviewing a research proposal. It arrived polished, every box filled, every section written in the language funders want to hear. The engagement plan was there. Patients would be consulted. An advisory board would provide input. On paper it was complete.
And I felt the same thing I heard in that clinician’s remark, only dressed in better manners. Nowhere in those tidy paragraphs could I find the place where a patient could change the answer. The seat was there. The say was not.
A patient who can be heard but not heeded is just a more polite version of “the science speaks for itself.”
What the numbers say
In 2018, a team led by Joanna Crocker published a review in The BMJ that pooled many trials and asked a plain question: does involving patients and the public help a trial recruit the people it needs?
The answer was yes. But the important part was in the comparison. When the involvement was generic — a public member here, a consultation there — the effect on hitting enrollment targets was barely there. When the people involved had real lived experience of the condition, the odds of meeting recruitment goals roughly tripled.
A generic seat moved almost nothing. Lived experience with real influence moved everything.
That is the clinician’s sentence answered in his own language — the language of evidence. The science speaks more clearly, not less, when the patient is in it. The questions get sharper. The outcomes that get measured become the ones that matter to people living the condition. And the trial is far more likely to find its participants at all. That last point is not small. A trial that cannot recruit answers nothing, after spending a great deal of money to do it.
Let me be honest about the limits. The same review found the evidence on keeping people enrolled too thin to call. The broader claim that engagement improves the overall quality of the science is reasonable but not yet proven, and the researchers who built this field say so plainly. What we can say is narrower and stronger: patients with lived experience make the science ask better questions and measure things that matter. The patient is not the soft part of the work. The patient is the part that tells you whether you measured the right thing.
A mandate is a floor, not a building
The clinician said patients are not needed. A funder’s mandate says the opposite — patients are required. You might think that settles it. Make funders demand engagement and the problem is solved. And mandates do work, up to a point. They are the reason that polished proposal had an engagement plan at all. A rule can make a chair appear.
But a rule cannot make anyone listen. That is why the proposal felt hollow even though it broke none of the rules — and why “patients are required” can end up in the same place as “patients are not needed.” A mandate builds the floor. It does not build the house. You can require a patient in the room and still arrange the room so nothing the patient says can move anything. The form gets filled out. The power stays where it was.
What turns a requirement into a real relationship is not more rules. It is researchers who have done it once, felt the study get better in their hands, and become believers — and then told their colleagues. Conviction spreads sideways, peer to peer, far better than it comes down from a policy. I have watched one researcher who got it change a whole working group, just by being the credible voice in the room saying this made my work better, not slower.
The part that gives me hope
This is why I am writing now instead of a year from now. The pieces of a real shift are showing up — not as slides at a conference, but as things that exist.
PCORI — the Patient-Centered Outcomes Research Institute — has started backing studies led by two principal investigators as equals: one a scientist, one a community partner. Not an advisor to the work. A leader of it. The BMJ, one of the most respected medical journals in the world, began paying the patients who review its papers — because a thing you pay for is a thing you have stopped calling a favor. Small precedents. But precedents are how impossible becomes standard.
I have spent twenty-seven years in support-group rooms, listening to people say in plain words what living with chronic pain costs them. The jobs. The marriages. The mornings. That testimony is not decoration. It is a kind of data no instrument can capture, and it is the only thing that can tell a scientist whether the number they moved is a number that matters.
So I would answer that clinician this way, with respect, because I think he meant it honestly. You are right that the science speaks. But it speaks only the part of the truth an instrument can measure. The rest of the truth — whether any of this improves one real day in one real life — lives in the patient. You cannot hear it through a microscope. You have to ask.
Give a patient a chair and you have been polite. Give a patient the power to change the study and you have done better science.
The evidence is finally on the side of the thing that was always right.
The views, positions, and recommendations expressed in this article are based on my personal experiences and independent research. They are solely my own and do not necessarily reflect the views, policies, or positions of the American Chronic Pain Association (ACPA), or any federal program or committee on which I serve. AI was used for research, editing, and organizing; final text is my own.